8th Antibody Industrial Symposium 2020
June 22 - June 23
The 8th Antibody Industrial Symposium AIS2020 jointly organized by the scientific society LabEx MAbImprove and MabDesign, the French association of the Immunotherapy Industrial sector, will be held the 22nd and 23rd of June 2020 in Montpellier. This year edition will focus on a major theme chosen by the Scientific Advisory Board: “Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases”. It includes keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies.
The next frontier of Ab-based therapeutics for fighting diseases is the production and application of higher-order multispecific Abs or Ab-like molecules, as well as novel cytokine-based biologics or engineered artificial chimeric antigen receptors (CARs). Indeed multispecific Abs and next-generation immunocytokines provide promising platform for the development of novel therapeutic concepts that could facilitate the generation of safer, more effective pharmaceuticals. Re-directing immune cells with engineered CARs is an exciting approach for efficient adoptive cell therapy. AIS2020 will cover the multifaceted mechanisms induced by novel multimer derivatives, cytokine-based products and CARs in different pathophysiological situations. It will also focus on CMC developability and the early clinical development.
The program will allow opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.